Table 1.
Clinical and pathological characteristics of 328 hepatocellular carcinoma (HCC) patients.
| Characteristics | N (%) |
|---|---|
| Age (Mean ± SD and range) (years) | 56.5 ± 13.9 (19–87) |
| Gender | |
| Male | 267 (81.4%) |
| Female | 61 (18.6%) |
| Drinking historya | |
| Yes | 106 (32.5%) |
| No | 220 (67.5%) |
| Virus infection | |
| None | 23 (7.0%) |
| HBV | 233 (71.0%) |
| HCV | 54 (16.5%) |
| HBV + HCV | 18 (5.5%) |
| Tumor size (Mean ± SD and range) (cm) | 6.3 ± 4.3 (0.8–20.5) |
| ≦5 | 170 (51.8%) |
| >5 | 158 (48.2%) |
| Serum AFP (ng/mL)b | |
| ≦200 | 215 (66.4%) |
| >200 | 109 (33.6%) |
| Edmondson Grade | |
| 1 + 2 | 156 (52.4%) |
| 3 + 4 | 172 (47.6%) |
| TNM stage | |
| I + II | 217 (66.2%) |
| III + IV | 111 (33.8%) |
| Vascular invasion | |
| Absent | 179 (54.6%) |
| Present | 149 (45.4%) |
| Tumor number | |
| Solitary | 192 (58.5%) |
| Multiple | 136 (41.5%) |
| Cirrhosis | |
| No | 172 (52.4%) |
| Yes | 156 (47.6%) |
| Metastasis | |
| No | 277 (84.5%) |
| Yes | 51 (15.5%) |
| Relapsec | |
| No | 130 (40.2%) |
| Yes | 193 (59.8%) |
| RFS duration median (range) | 27.4 (0.6–138.8 months) |
| Outcome | |
| Alive | 259 (79.0%) |
| Dead | 69 (21.0%) |
| OS duration median (range) | 53.2 (0.8–138.8 months) |
a
Data missing in two samples.
b
Data missing in four samples.
c
Data missing in five samples.